Ethical Considerations for Managing Psychogenic Pruritus in Patients With Delusional Parasitosis

research funding from Regeneron Pharmaceuticals, Inc and Sanofi. He is also an investigator for Pfizer, Eli Lilly, Novartis, Escient, and Sanofi. These entities had no role whatsoever in the conception, design, or execution of this work, and Dr Yosipovitch received no compensation, honoraria, scholarship, or financial incentive of any kind in association with this work. Mr Shaikh and Ms Khalil have no Conflicts of interest to disclose.